MOTS-c vs Pancragen
Side-by-side price comparison across every tracked vendor. Updated every 4–6 hours.
Pepticker may earn affiliate commissions (typically 5-20%) from linked vendors. See our Affiliate Disclosure.
MOTS-c
Mitochondrial exerkine
| Vendor | Grade | Risk | Price | $/mg | Trend | Stock | |
|---|---|---|---|---|---|---|---|
| Pure Lab Peptides US | B- | Operational | $49.99 ◎ Best $/mg | $10.00 | Out | Buy with code → |
Pancragen
Khavinson pancreatic bioregulator
About MOTS-c
A 16-residue peptide encoded within the mitochondrial 12S rRNA. Studied as an exercise-mimetic exerkine for metabolic health and longevity.
About Pancragen
Pancragen is a Khavinson short-peptide bioregulator (Lys-Glu-Asp-Trp / KEDW) originally isolated from pancreatic tissue extracts in Russian gerontology research. It has been studied in animal and cell-culture models for islet-cell function, glucose-handling parameters, and pancreatic tissue ageing, alongside other organ-targeted Khavinson tetrapeptides such as Livagen (liver) and Cortagen (cerebral cortex). Sold by research-peptide vendors at 5–20 mg vial sizes for laboratory work; not approved by FDA, MHRA, Health Canada, or TGA for human use. Research-use only — Pepticker does not provide medical advice and this entry summarises published preclinical research, not a dosing protocol.